Income Statement - Neumora Therapeutics, Inc. (NMRA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of revenue | 5.00 | 0.67 | 2.70 | 1.55 | |||
| Gross profit | -5.00 | -0.67 | -2.70 | -1.55 | |||
| Total operating expenses | 236.16 | 263.46 | 187.53 | 135.87 | 237.32 | 95.52 | |
| Operating income | -241.16 | -263.46 | -188.19 | -135.87 | -237.32 | -95.52 | |
| Non-operating income (net) | 4.36 | 19.86 | -47.46 | 4.97 | 0.01 | -3.75 | 0.00 |
| Income before tax | -236.80 | -243.61 | -235.66 | -130.90 | -237.31 | -99.27 | |
| Income tax expense | 0.13 | 0.18 | 0.27 | -4.56 | 0.30 | -0.10 | |
| Net income | -236.93 | -243.79 | -235.93 | -130.90 | -237.31 | -99.27 |
Show Quarterly Income Statement
Income Statement - Neumora Therapeutics, Inc. (NMRA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Cost of revenue | 0.01 | 5.00 | 0.32 | 0.16 | 0.16 | 0.17 | 1.02 | 0.99 | 0.96 | 0.93 | 0.92 | 0.48 | 0.37 | 0.32 | ||||||||
| Gross profit | -0.01 | -5.00 | -0.16 | -0.16 | -0.17 | -1.02 | -0.99 | -0.96 | -0.93 | -0.92 | -0.48 | -0.37 | -0.32 | |||||||||
| Total operating expenses | 52.86 | 58.48 | 52.70 | 54.04 | 70.94 | 62.92 | 76.65 | 63.82 | 60.07 | 49.93 | 56.86 | 42.06 | 39.17 | 30.72 | 30.60 | 31.31 | 43.24 | 26.55 | 178.13 | 17.20 | 15.45 | 19.53 |
| Operating income | -52.86 | -58.48 | -57.70 | -54.04 | -70.94 | -62.92 | -76.65 | -63.82 | -60.07 | -50.10 | -56.86 | -42.06 | -39.17 | -30.72 | -30.60 | -31.31 | -43.24 | -26.55 | -178.13 | -17.20 | -15.45 | -19.53 |
| Non-operating income (net) | -0.56 | -0.97 | 0.95 | 1.33 | 3.05 | 4.10 | 4.15 | 5.25 | 6.35 | -58.36 | 3.84 | 3.52 | 3.54 | 2.57 | 1.26 | 0.94 | 0.19 | -0.42 | 0.10 | 0.19 | 0.14 | -0.47 |
| Income before tax | -53.43 | -59.45 | -56.76 | -52.71 | -67.89 | -58.82 | -72.49 | -58.58 | -53.72 | -108.46 | -53.03 | -38.54 | -35.63 | -28.15 | -29.34 | -30.37 | -43.04 | -26.97 | -178.03 | -17.01 | -15.30 | -20.00 |
| Income tax expense | 0.03 | 0.03 | 0.11 | 0.05 | 0.13 | -6.37 | 0.27 | -4.01 | -3.56 | -3.57 | -2.29 | -1.41 | -0.78 | -0.09 | -0.18 | |||||||
| Net income | -53.46 | -59.45 | -56.76 | -52.73 | -67.99 | -58.82 | -72.55 | -58.70 | -53.72 | -108.73 | -53.03 | -38.54 | -35.63 | -28.15 | -29.34 | -30.37 | -43.04 | -26.97 | -178.03 | -17.01 | -15.30 | -20.00 |